Recognition of Fixed Asset Impairment Losses and Expenses Associated with Restructuring
First written in FY2021-Q1. 1 of 13 entries say "Advanced", first in FY2021-Q2. Latest entry: FY2026.
1 other company's latest entry also says "Mitigated".
- FY2026MitigatedAnnual report
「Impairment loss 5,870 151」
Impairment losses recognized in the previous fiscal year for production equipment in Thailand and other assets fell substantially from ¥5.870 billion to ¥151 million in the current fiscal year. - FY2025Recognition of Impairment Losses on Production Equipment in ThailandAnnual report
「Due to deteriorating market conditions and other factors, the carrying amounts of certain assets were written down to their recoverable amounts.」
Due to changes in the business structure and market conditions, the Company recognized ¥5.870 billion in impairment losses, including ¥5.716 billion related to production equipment in Thailand. - FY2024RestatedAnnual report
「In connection with the implementation of this restructuring, the Company recognized ¥23,002 million as losses related to the China business, including compensation to related business partners and suppliers.」
For the full fiscal year, the Company recognized ¥23.002 billion in losses related to the China business, including compensation to business partners and suppliers, in connection with a fundamental review of its China strategy and restructuring. - FY2024-Q3Recognition of Losses Related to Failure to Meet the China Business PlanAnnual report
「In connection with the implementation of this restructuring, the Company recognized ¥24,669 million as losses related to the China business, including compensation to related business partners and suppliers.」
In connection with a fundamental review of its China strategy and restructuring, the Company recognized ¥24.669 billion in losses related to the China business, including compensation to related business partners and suppliers. - FY2024-Q2Recognition of Losses Related to the China BusinessAnnual report
「In connection with the implementation of this restructuring, the Company recognized ¥26,230 million as losses related to the China business, including compensation to related business partners and suppliers.」
In connection with the restructuring of its China strategy, the Company recognized ¥26.230 billion in losses related to the China business, including compensation to related business partners and suppliers. - FY2023-Q3Impairment losses increase againAnnual report
「Impairment loss 91 4,130」
Impairment losses increased from ¥91 million in the same period of the previous fiscal year to ¥4,130 million. Although still below the substantial impairment loss related to restructuring in the previous fiscal year, the figure increased again after declining through the previous quarter. - FY2023-Q1Elimination of impairment lossAnnual report
「Impairment loss 25 －」
Impairment losses related to restructuring decreased from ¥25 million in the same period of the previous fiscal year to zero in the first quarter of the current fiscal year. - FY2022-Q3Slight increase in impairment lossesAnnual report
「Impairment loss 91」
Impairment losses related to restructuring increased from ¥50 million on a cumulative second-quarter basis to ¥91 million on a cumulative third-quarter basis, but remained below the ¥107.534 billion recorded in the same period of the previous fiscal year. - FY2022-Q2Slight increase in impairment lossesAnnual report
「Impairment loss *1 50」
Cumulative impairment losses for the second quarter were ¥50 million, up from ¥25 million in the first quarter, but substantially below the ¥107.495 billion recorded in the same period of the previous fiscal year. - FY2022-Q1Sharp reduction in impairment lossesAnnual report
「Impairment loss *1 25」
While an impairment loss of ¥107.488 billion was recognized in the first quarter of the previous fiscal year in connection with restructuring, the impairment loss in the first quarter of the current fiscal year was ¥25 million, representing a substantial reduction in the amount recognized. - FY2021-Q3Cumulative increase in impairment lossesAnnual report
「The impairment loss recognized during the cumulative third quarter of the current fiscal year was ¥116,871 million.」
Impairment losses related to restructuring increased from ¥116,302 million on a cumulative second-quarter basis to ¥116,871 million. Business restructuring costs totaled ¥32.1 billion, and the disclosure also stated that additional costs could arise as restructuring progresses. - FY2021-Q2AdvancedAnnual report
「The impairment loss recognized during the cumulative second quarter of the current fiscal year was ¥116,302 million.」
Impairment losses related to restructuring increased from ¥115.916 billion in the first quarter to ¥116.302 billion on a cumulative second-quarter basis. The reasons for the impairment and restructuring costs were also specified, including the reorganization of the sales structure, the reorganization and downsizing of the production structure, and the suspension of new product launches for Europe. - FY2021-Q1First statedAnnual report
「The impairment loss recognized during the cumulative first quarter of the current fiscal year was ¥115,916 million. Business restructuring costs comprised ¥8,428 million in impairment losses on fixed assets at sales and production sites associated with the reorganization and strengthening of the sales and production structure in Japan, and ¥1,164 million in special retirement payments at overseas subsidiaries.」
Impairment losses of ¥115.916 billion on production and sales-related assets and business restructuring costs of ¥9.592 billion were recognized in the first quarter, following updated future sales volume forecasts and the reorganization of the production structure under the new medium-term management plan, “Small but Beautiful.”